Advertisement
Document › Details
Bico Group AB. (11/13/23). "Press Release: Maria Forss Assumes Office as BICO’s CEO and President on November 20, 2023".
Organisation | Bico Group AB (publ) | |
Group | Bico (Group) | |
Organisation 2 | Vitrolife AB | |
Group | Vitrolife (Group) | |
Product | laboratory equipment and instruments | |
Product 2 | LIFE SCIENCES | |
Person | Forss, Maria (Bico Group 202311– CEO before Vitrolife + AstraZeneca) | |
Person 2 | Gatenholm, Erik (Cellink 201908 CEO + Co-Founder RESIGNED as CEO of Bico 11/23 LEFT Board 5/24) | |
Maria Forss assumes office on November 20, 2023, and to ensure a seamless transition, Erik Gatenholm will during a quarter assist with her onboarding process. Thereafter, he will transition into the role as a senior advisor to BICO.
Erik Gatenholm’s remuneration will be less than 50% of his previous compensation. He will not partake in any bonus programs and will decline Board compensation as long as he maintains his operational engagement.
Maria Forss has extensive international experience from leading positions in both medtech and pharma companies, such as Vitrolife and AstraZeneca. The last years within Vitrolife Maria Forss has as the Senior Vice President led the Consumables Business Area and before that she was the Vice President of Business Development and Global Marketing. Maria Forss has successfully developed businesses through the whole value chain and in the whole product life cycle as well as acquisitions and integration of companies.
For more information about the appointment of Maria Forss, please read the press release from August 21, 2023.
For further information, please contact:
Erik Gatenholm, President & CEO, BICO Group AB
Telephone US: +1 (650) 515-5566
Telephone Sweden: +46 73 267 00 00
E-mail: eg@bico.com
Jacob Thordenberg, Chief Financial Officer, BICO Group AB
Phone: +46 73 534 88 84
E-mail: jt@bico.com
The information was submitted for publication, through the agency of the contact persons set out above, on November 13, 2023 at 7.30pm CET.
About BICO
BICO is a leading provider of life science solutions and laboratory automation that enable more efficient development of new treatments with more specificity and less need for animal testing.
The company uses bioconvergence as its operating system, combining advanced technologies with biology to streamline and automate workflows within the pharmaceutical and biopharma industries.
With 32,000+ instruments installed in over 65 countries, BICO products and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 11,000 publications.
Operating through three business areas – Bioprinting, Biosciences and Bioautomation – the BICO Group strives towards the long-term ambition of enabling the reduction of the world’s organ shortage and speeding up drug development to create the future of life-saving treatments.
BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO. www.bico.com
Record changed: 2024-01-20 |
Advertisement
More documents for Bico (Group)
- [1] Bico Group AB. (7/10/24). "Press Release: Andréas Joersjö Appointed as General Counsel for Bico Group AB"....
- [2] Bico Group AB. (3/15/24). "Press Release: Founders Leave after Eight Years"....
- [3] Bico Group AB. (11/13/23). "Press Release: BICO Has Divested Ginolis through a Management Buy-out to Ginolis’ Current CEO Kauko Väinämö. The Purchase Price amounted to €1"....
- [4] Bico Group AB. (10/11/23). "Press Release: Cellink and the University of California, San Diego Partner to Open a 3D Bioprinting Centre of Excellence". San Diego, CA....
- [5] Bico Group AB. (8/21/23). "Press Release: Maria Forss Is Appointed New President and CEO of Bico Group AB (publ)"....
- [6] Bico Group AB. (8/21/23). "Press Release: Bico Announces Goodwill Impairment Predominantly Due to Increased WACC, and Write-downs of Assets"....
- [7] Bico Group AB. (8/3/23). "Press Release: Bico Divests Berlin Property for a Total of EUR 21m"....
- [8] Bico Group AB. (2/27/23). "Press Release: Bico Introduces New Life Sciences Manufacturing Platform Integrating ABB Robotics Technology"....
- [9] Bico Group AB. (1/2/23). "Press Release: Bico Group Appoints New CFO"....
- [10] Sartorius AG. (12/8/22). "Press Release: Sartorius Agrees with Bico on Strategic Cooperation as well as a 10 Percent Capital Investment". Göttingen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top